106 related articles for article (PubMed ID: 25691722)
1. Viral clearance of traditional unit operations: virus-retentive filtration.
Chen Q; Chen D
PDA J Pharm Sci Technol; 2015; 69(1):142-53. PubMed ID: 25691722
[No Abstract] [Full Text] [Related]
2. Viral clearance using traditional, well-understood unit operations: session 1.2. Anion exchange chromatography; and session 1.3. Protein a chromatography.
Roush D
PDA J Pharm Sci Technol; 2015; 69(1):154-62. PubMed ID: 25691723
[No Abstract] [Full Text] [Related]
3. Session 2/3: integrated viral clearance strategy and case studies.
Willkommen H
PDA J Pharm Sci Technol; 2015; 69(1):183-94. PubMed ID: 25691726
[No Abstract] [Full Text] [Related]
4. Session 4: overall integrated viral clearance and adventitious agents strategy.
Blümel J; Tounekti O
PDA J Pharm Sci Technol; 2015; 69(1):195-205. PubMed ID: 25691727
[No Abstract] [Full Text] [Related]
5. 2013 viral clearance symposia - session 5. Conference summary: key discussion and outcomes, pending questions, and proposed experiments.
Blümel J; Roush D
PDA J Pharm Sci Technol; 2015; 69(1):206-10. PubMed ID: 25691728
[No Abstract] [Full Text] [Related]
6. Session 1.5: other viral clearance and inactivation approaches (multimodal chromatography, membrane chromatography, chemical precipitation).
Hubbard B
PDA J Pharm Sci Technol; 2015; 69(1):173-82. PubMed ID: 25691725
[No Abstract] [Full Text] [Related]
7. Mixing monoclonal antibody formulations using bottom-mounted mixers: impact of mechanism and design on drug product quality.
Gikanga B; Chen Y; Stauch OB; Maa YF
PDA J Pharm Sci Technol; 2015; 69(2):284-96. PubMed ID: 25868994
[TBL] [Abstract][Full Text] [Related]
8. Viral Clearance Using Traditional, Well-Understood Unit Operations Session 1.2: Virus-Retentive Filtration.
Roush D; Ma J
PDA J Pharm Sci Technol; 2016 Sep; 70(5):417-427. PubMed ID: 27516492
[No Abstract] [Full Text] [Related]
9. Prevention of stirring-induced microparticle formation in monoclonal antibody solutions.
Ishikawa T; Kobayashi N; Osawa C; Sawa E; Wakamatsu K
Biol Pharm Bull; 2010; 33(6):1043-6. PubMed ID: 20522974
[TBL] [Abstract][Full Text] [Related]
10. A three plus three parameters mechanistic model for viral filtration.
Misra P; Sinha A; Rathore AS; Shukla A; Mir FQ
Biotechnol Prog; 2017 Nov; 33(6):1538-1547. PubMed ID: 28699320
[TBL] [Abstract][Full Text] [Related]
11. Achieving a Successful Scale-Down Model and Optimized Economics through Parvovirus Filter Validation using Purified TrueSpikeTM Viruses.
De Vilmorin P; Slocum A; Jaber T; Schaefer O; Ruppach H; Genest P
PDA J Pharm Sci Technol; 2015; 69(3):440-9. PubMed ID: 26048749
[TBL] [Abstract][Full Text] [Related]
12. Toward biosimilar monoclonal antibodies.
Schneider CK; Kalinke U
Nat Biotechnol; 2008 Sep; 26(9):985-90. PubMed ID: 18779806
[No Abstract] [Full Text] [Related]
13. Viral clearance using traditional, well-understood unit operations (session I): virus-retentive filtration.
Chen D
PDA J Pharm Sci Technol; 2014; 68(1):38-50. PubMed ID: 24504235
[No Abstract] [Full Text] [Related]
14. The impact of long-term secukinumab treatment on Epstein-Barr virus and cytomegalovirus loads in patients with psoriasis.
Chiu HY; Chan CC; Tsai TF
Int J Dermatol; 2016 Nov; 55(11):e600-e602. PubMed ID: 27261186
[No Abstract] [Full Text] [Related]
15. Formulation and manufacturability of biologics.
Shire SJ
Curr Opin Biotechnol; 2009 Dec; 20(6):708-14. PubMed ID: 19880308
[TBL] [Abstract][Full Text] [Related]
16. Proceedings of the 2013 Viral Clearance Symposium (Princeton, NJ).
Roush D; Brorson K; Levy R
PDA J Pharm Sci Technol; 2015; 69(1):140-1. PubMed ID: 25691721
[No Abstract] [Full Text] [Related]
17. King in the kingdom of uncertainty.
Nat Biotechnol; 2005 Sep; 23(9):1025. PubMed ID: 16151376
[No Abstract] [Full Text] [Related]
18. Analysis of viral clearance unit operations for monoclonal antibodies.
Miesegaes G; Lute S; Brorson K
Biotechnol Bioeng; 2010 Jun; 106(2):238-46. PubMed ID: 20073086
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous administration of monoclonal antibodies: a small space to inject, a big challenge to conquer.
Shameem M
Ther Deliv; 2016; 7(1):5-6. PubMed ID: 26652618
[No Abstract] [Full Text] [Related]
20. Flexibility--the guiding principle for antibody manufacturing.
Carson KL
Nat Biotechnol; 2005 Sep; 23(9):1054-8. PubMed ID: 16151390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
